Lithium may have turned a corner in October, while gold and copper both touched record highs before late pullbacks.

Optiscan has pioneered the world’s first miniaturised confocal microscope that allows doctors, pathologists and veterinarians ...

Small caps continued to shine in October, with the ASX Small Ordinaries rising 2%, achieving a 25% YTD gain and significantly outperforming the 12% increase in the ASX 200, according to S&P Dow Jones ...

With most of its sales now coming from the US, glaucoma device maker Nova Eye Medical is steering a course through global trade turbulence.

Armed with the latest tech and a human coach, The Australian's tech editor learned what makes the difference in the pursuit ...

Gallium fever lifts Mount Ridley to three-year highs as Western Yilgarn expands its footprint and Locksley lands a US$191m ...

Rising inflation has ruined chances of an early Christmas gift for people with home loans. See the 12 biggest cost culprits.

At a time of strong tin prices and growing demand, Sky Metals owns one of only a handful of tin development projects in the world.

Tech’s renewed appetite for nuclear energy is reshaping the market – and Australian explorers operating in the US stand to ...

The ASX slipped by lunch as traders braced for the RBA. Healthcare and property names copped a beating, banks found a tailwind.

Frontier Energy is pushing ahead with development of its Waroona renewable energy project after landing confirmation of peak capacity credits.

Uscom chairman Professor Rob Phillips says the device maker's misfortune was shaped by a series of exogenous events, including US tariffs.